Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Mol Sci
2017 Feb 14;182:. doi: 10.3390/ijms18020403.
Show Gene links
Show Anatomy links
A Plant Proteinase Inhibitor from Enterolobium contortisiliquum Attenuates Pulmonary Mechanics, Inflammation and Remodeling Induced by Elastase in Mice.
Theodoro-Júnior OA
,
Righetti RF
,
Almeida-Reis R
,
Martins-Oliveira BT
,
Oliva LV
,
Prado CM
,
Saraiva-Romanholo BM
,
Leick EA
,
Pinheiro NM
,
Lobo YA
,
Martins MA
,
Oliva ML
,
Tibério IF
.
???displayArticle.abstract???
Proteinase inhibitors have been associated with anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment for emphysema. Our aim was to evaluate the effects of a plant Kunitz proteinase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on several aspects of experimental elastase-induced pulmonary inflammation in mice. C57/Bl6 mice were intratracheally administered elastase (ELA) or saline (SAL) and were treated intraperitoneally with EcTI (ELA-EcTI, SAL-EcTI) on days 1, 14 and 21. On day 28, pulmonary mechanics, exhaled nitric oxide (ENO) and number leucocytes in the bronchoalveolar lavage fluid (BALF) were evaluated. Subsequently, lung immunohistochemical staining was submitted to morphometry. EcTI treatment reduced responses of the mechanical respiratory system, number of cells in the BALF, and reduced tumor necrosis factor-α (TNF-α), matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-12 (MMP-12), tissue inhibitor of matrix metalloproteinase (TIMP-1), endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS)-positive cells and volume proportion of isoprostane, collagen and elastic fibers in the airways and alveolar walls compared with the ELA group. EcTI treatment reduced elastase induced pulmonary inflammation, remodeling, oxidative stress and mechanical alterations, suggesting that this inhibitor may be a potential therapeutic tool for chronic obstructive pulmonary disease (COPD) management.
Figure 1. (A) Median and standard error (SE) of respiratory system elastance (Ers) for all experimental groups. * p < 0.05, compared with the saline (SAL), SAL-Enterolobium contortisiliquum trypsin inhibitor (EcTI) and elastase (ELA)-EcTI groups; (B) Median and SE of respiratory system resistance (Rrs) for all experimental groups. * p < 0.05, compared with the SAL-EcTI and ELA-EcTI groups; (C) Median and standard error of Raw for all experimental groups. * p < 0.05, compared with the SAL, SAL-EcTI and ELA-EcTI groups; (D) Mean and SE of Gtis for all experimental groups. There were no significant differences among the groups; (E) Median and SE of Htis for all experimental groups. * p < 0.05, compared with the SAL, SAL-EcTI and ELA-EcTI groups; (F) Photograph of the ENO and the mechanical evaluation: (1) Mylar bag for exhaled nitric oxide (ENO); (2) animal connected to a mechanical ventilator; (3) mechanical ventilator for small animals (Flexivent) and (4) nitric oxide filter.
Figure 3. Mean and standard error of exhaled nitric oxide (ENO) for the four experimental groups. * p < 0.05, compared with the SAL and SAL-EcTI groups. ** p < 0.05, compared with the SAL and ELA groups.
Figure 5. Inflammatory, remodeling and oxidative stress markers in the alveolar walls: photomicrographs of the results of the immunohistochemical analyses of the extracellular matrix inflammatory, remodeling and oxidative stress process in the alveolar walls to detect neutrophils, TNF-α, MMP-9, TIMP-1, iNOS and 8-iso-PGF2α. Magnification of 400×. All the following experimental groups are represented: SAL, ELA, SAL-EcTI and ELA-EcTI. We observed that the proteinase inhibitor, EcTI attenuated the cellular response induced by elastase. Scale bar = 30 µm.
Figure 6. Inflammatory, remodeling and oxidative stress markers in the airway walls; photomicrographs of the results of the immunohistochemical analyses of the inflammatory, remodeling and oxidative stress process in the airway walls used to detect neutrophils, TNF-α, MMP-9, TIMP-1, iNOS and 8-iso-PGF2α. Magnification of 400×. All the following experimental groups are represented: SAL, ELA, SAL-EcTI and ELA-EcTI. We observed that the proteinase inhibitor EcTI attenuated the cellular response induced by elastase. Scale bar = 30 µm.
Figure 7. Timeline of the experimental protocol. On the first day of the protocol, animals received intratracheal instillation of elastase or vehicle. 2 h after the intratracheal instillation, animals received an intraperitoneal injection of the treatment (EcTI or saline). On the fifteenth day, animals received the second dose of treatment (EcTI or saline). On the twenty-first day, animals received the last dose of saline or EcTI.
Barnes,
COPD: current therapeutic interventions and future approaches.
2005, Pubmed
Barnes,
COPD: current therapeutic interventions and future approaches.
2005,
Pubmed
Batista,
Preliminary crystallographic studies of EcTI, a serine proteinase inhibitor from Enterolobium contortisiliquum seeds.
2001,
Pubmed
Benetazzo,
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease.
1999,
Pubmed
Chung,
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.
2008,
Pubmed
Churg,
Proteases and emphysema.
2005,
Pubmed
De Leo,
PLANT-PIs: a database for plant protease inhibitors and their genes.
2002,
Pubmed
Deshmukh,
Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation.
2005,
Pubmed
Guarnieri,
A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema.
2010,
Pubmed
Hanaoka,
Carbocisteine protects against emphysema induced by cigarette smoke extract in rats.
2011,
Pubmed
Hantos,
Lung volumes and respiratory mechanics in elastase-induced emphysema in mice.
2008,
Pubmed
Ito,
Tissue heterogeneity in the mouse lung: effects of elastase treatment.
2004,
Pubmed
Liu,
Human airway trypsin-like protease induces mucin5AC hypersecretion via a protease-activated receptor 2-mediated pathway in human airway epithelial cells.
2013,
Pubmed
Lopes,
A comparative study of extracellular matrix remodeling in two murine models of emphysema.
2013,
Pubmed
Luisetti,
MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial.
1996,
Pubmed
Mahadeva,
Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.
2002,
Pubmed
Martins-Olivera,
The Plant-Derived Bauhinia bauhinioides Kallikrein Proteinase Inhibitor (rBbKI) Attenuates Elastase-Induced Emphysema in Mice.
2016,
Pubmed
Nakahata,
The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines.
2011,
Pubmed
Neuhof,
Effect of plant Kunitz inhibitors from Bauhinia bauhinioides and Bauhinia rufa on pulmonary edema caused by activated neutrophils.
2003,
Pubmed
Oliva,
Action of plant proteinase inhibitors on enzymes of physiopathological importance.
2009,
Pubmed
Owen,
The cell biology of leukocyte-mediated proteolysis.
1999,
Pubmed
Owen,
Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.
2008,
Pubmed
Pauwels,
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
2001,
Pubmed
Pauwels,
Burden and clinical features of chronic obstructive pulmonary disease (COPD).
2004,
Pubmed
Pigati,
Y-27632 is associated with corticosteroid-potentiated control of pulmonary remodeling and inflammation in guinea pigs with chronic allergic inflammation.
2015,
Pubmed
Plantier,
Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice.
2007,
Pubmed
Prado,
Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs.
2005,
Pubmed
Righetti,
Effects of Rho-kinase inhibition in lung tissue with chronic inflammation.
2014,
Pubmed
,
Echinobase
Sakoda,
Sakuranetin reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflammation.
2016,
Pubmed
,
Echinobase
Scuri,
Inhaled porcine pancreatic elastase causes bronchoconstriction via a bradykinin-mediated mechanism.
2000,
Pubmed
Selman,
Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in Guinea pigs.
2003,
Pubmed
Shapiro,
Animal models for COPD.
2000,
Pubmed
Shapiro,
Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.
2003,
Pubmed
Shapiro,
Proteolysis in the lung.
2003,
Pubmed
Suzuki,
Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice.
2009,
Pubmed
Turk,
Targeting proteases: successes, failures and future prospects.
2006,
Pubmed
WEIBEL,
Principles and methods for the morphometric study of the lung and other organs.
1963,
Pubmed
Wright,
A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels.
2003,
Pubmed
de Paula,
Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.
2012,
Pubmed